FdaApplication
ANDA 213628
Identifiers
- fda_app_no: ANDA213628
Properties
| Property | Value |
|---|---|
| applicant_name | CADILA PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2021-06-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ERYTHROMYCIN | ERYTHROMYCIN | 500MG | TABLET;ORAL |
| ERYTHROMYCIN | ERYTHROMYCIN | 250MG | TABLET;ORAL |
2 products